VYNE THERAPEUTICS INC (VYNE)

US92941V3087 - Common Stock

2.62  +0.12 (+4.8%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
424.00K480.00K930.00K20.99M0.00
Cost Of Goods
N/AN/A3.35M1.39MN/A
Gross Profit
N/AN/A11.41M19.60MN/A
Operating Expenses
29.68M34.77M39.84M272.15M76.24M
Research and Development
16.31M18.39M19.54M43.53M53.76M
Selling, General, and Administrative Expenses
13.38M16.39M20.30M89.54M22.48M
Operating Income
-29.26M-34.30M-38.91M-252.55M-76.24M
Interest Income/Expense
N/A0.00-5.61M-4.39M2.54M
Other Income/Expense
1.39M360.00K-140.00K1.11MN/A
Income Before Taxes
-27.87M-33.93M-44.66M-255.83M-73.70M
Income Tax
0.0010.00K-450.00K-260.00KN/A
Net Income
-28.45M-23.21M-73.33M-255.57M-73.70M
EBITDA
N/A-34.23M-38.80M-252.21M-76.18M
 
Per Share Data
EPS Diluted Total Ops
-2.76-7.27-25.63-141.98-223.33
Non GAAP EPS
-7.04-11.07-16.75-5.75-12.36
 
Statistics
Gross Profit Margin
N/AN/A1226.56%93.38%N/A
Profit Margin
-6710.38%-4835.42%-7884.95%-1217.58%N/A
Operating Profit Margin
-6900.47%-7145.83%-4183.87%-1203.19%N/A

All data in USD

Charts